CereVasc
PrivateLast Round
Series C
Jun 4, 2026
Est. Valuation
$135M
Total Funding Raised
$198.9M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
CereVasc is a medical device company that develops minimally invasive endovascular treatments for neurological diseases, including its flagship eShunt System for communicating hydrocephalus.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CereVasc Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
CereVasc Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jun 4, 2026 | ||||
| Series B | May 13, 2024 | ||||
| Series A | Jun 9, 2020 |
Key People
Founding team and executive leadership
CereVasc Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bain Capital Life Sciences | Series C, Series B |
| Perceptive Advisors | Series C, Series A, Series B |
| Xontogeny | Series B, Series A |
| Bain Capital, LP | Series B |
| Johnson & Johnson Innovation – JJDC | Series C |
| Johnson & Johnson Innovation - JJDC, Inc. | Series C |
| ATON Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 4, 2026
$85M round led by Piper Sandler & Co.
- May 13, 2024
$70M round led by Bain Capital, LP.
CereVasc Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about CereVasc's valuation, stock price, and market status.